SCYNEXIS, Inc. (SCYX) Comparison with companies in other sectors?

SCYNEXIS, Inc. has a share price of 39.02M. You can analyze SCYNEXIS, Inc. (SCYX) competitors across different market sectors through stock heatmaps.

What are SCYX's NET and operating margins?

SCYNEXIS, Inc. (SCYX) operating margin is around -15.26, and net profit margin is approximately -11.42 as of the latest reports.

In what way does SCYX's earnings per share (EPS) trend reflect its financial momentum?

SCYNEXIS, Inc. (SCYX) EPS is -0.56 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for SCYNEXIS, Inc. is -1.30, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for SCYNEXIS, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for SCYNEXIS, Inc. like P/E which is -1.33, P/B which is 0.71, and PEG which is 0.05. Compare them with sector averages to evaluate if the stock is priced fairly.

SCYNEXIS, Inc.

SCYX•NASDAQ

Healthcare

Drug Manufacturers - Specialty & Generic

$0.73

$-0.01(-1.07%)

Fundamental Analysis of SCYNEXIS, Inc. (SCYX)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-0.56

P/E Ratio

-1.30

ROE

-0.48%

Net Margin

-11.42%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$28.49M

Shares OutstandingTotal number of shares issued

$39.02M

Book Value/ShareNet worth per share

$1.02

Revenue/ShareAnnual revenue per share

$0.05

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.56

Net MarginNet income as percentage of revenue

-1141.59%

Operating MarginOperating income as percentage of revenue

-1526.34%

ROEReturn on shareholders' equity

-48.26%

ROAReturn on total assets

-39.89%

ROCEReturn on capital employed

-61.43%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.56

Cash/ShareCash and equivalents per share

$0.82

FCF YieldFree cash flow as percentage of market cap

-95.45%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for SCYXFinancial Ratios Analysis details for SCYX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for SCYXSector Benchmarking details for SCYX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for SCYNEXIS, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of SCYNEXIS, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account SCYNEXIS, Inc.'s unique business strengths and challenges.

Key Financial Metrics for SCYNEXIS, Inc.

For SCYNEXIS, Inc., essential financial indicators include EPS -0.56, PE -1.30, and ROE -0.48. These key ratios reveal insights into SCYNEXIS, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare SCYNEXIS, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of SCYNEXIS, Inc.

Metrics like Net Margin -1141.59% and ROA -39.89% shed light on how well SCYNEXIS, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether SCYNEXIS, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of SCYNEXIS, Inc.

Using ratios such as P/B Ratio 0.71 and PEG Ratio 0.05, investors can assess whether SCYNEXIS, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with SCYNEXIS, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for SCYNEXIS, Inc.

Financial health indicators, such as Debt/Equity Ratio 0.05 and Cash Flow $-0.56, provide a snapshot of SCYNEXIS, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like SCYNEXIS, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for SCYNEXIS, Inc.

Investing in SCYNEXIS, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at SCYNEXIS, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;